Medtronic Earnings Ahead, Multiple Top-Rated Analysts Cut Price Targets

Medtronic is scheduled to report its fiscal first-quarter earnings before the market opens on Tuesday, September 1.

Analysts expect the Dublin, Ireland-based company to post quarterly earnings per share of $1.39, up from $1.26 in the same period last year. The consensus revenue estimate for Medtronic's quarterly results is $9.54 billion. The company reported revenue of $8.54 billion in the year-ago period.

On August 20, the company's board declared a quarterly cash dividend of 72 cents per share of common stock.

Medtronic shares fell 2.2% on Thursday to close at $89.97. Readers can view the latest analyst ratings on the analyst stock ratings page. Readers can filter by stock ticker, company name, analyst firm, rating change, or other variables.

Let's take a look at how the most accurate analysts recently rated the company.

Needham analyst Mike Matson maintained a Buy rating on August 27, 2026, and raised the price target from $101 to $114. The analyst has a historical accuracy rate of 58%.

BTIG analyst Ryan Zimmerman maintained a Buy rating on August 18, 2026, with a price target of $91. The analyst has a historical accuracy rate of 65%.

UBS analyst Priya Sachdeva upgraded the stock from Neutral to Buy on July 28, 2026, and raised the price target from $85 to $100. The analyst has a historical accuracy rate of 67%.

TD Cowen analyst Joshua Jennings maintained a Buy rating on July 10, 2026, and lowered the price target from $119 to $100. The analyst has a historical accuracy rate of 57%.

Evercore ISI Group analyst Vijay Kumar maintained an Outperform rating on July 6, 2026, and lowered the price target from $106 to $105. The analyst has a historical accuracy rate of 64%.

Considering buying MDT stock? Here's what analysts say.